Teva Pharmaceutical Industries Limited
TEVA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalantā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
44 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$35.01
Price-1.13%
-$0.40
1Y
Price
Market Cap
$40.767b
Large
Price/Earnings 3y Avg5y Avg
12x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+22.0%
EBITDA Margin+9.3%
Net Profit Margin-5.2%
Free Cash Flow Margin+22.0%
EBITDA Margin+9.3%
Net Profit Margin-5.2%
Free Cash Flow MarginRevenue
$17.314b
+0.5%
1y CAGR+3.1%
3y CAGR+3.9%
5y CAGREarnings
$706m
+10.9%
1y CAGR+1.3%
3y CAGR+20.2%
5y CAGREPS
$0.60
+10.8%
1y CAGR+1.2%
3y CAGR+20.2%
5y CAGRBook Value
$7.761b
$39.857b
Assets$32.096b
Liabilities$16.874b
DebtDebt to Assets
42.3%
5.2x
Debt to EBITDAFree Cash Flow
$1.348b
+2.1%
1y CAGR+14.8%
3y CAGR+6.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company